Cadmium, active smoking and renal function deterioration in patients with type 2 diabetes

被引:11
|
作者
Oosterwijk, Milou M. [1 ]
Hagedoorn, Ilse J. M. [1 ]
Maatman, Ronald G. H. J. [2 ]
Bakker, Stephan J. L. [3 ]
Navis, Gerjan [3 ]
Laverman, Gozewijn D. [1 ,4 ]
机构
[1] Ziekenhuis Grp Twente, Dept Internal Med Nephrol, Zilvermeeuw 1, Almelo, Netherlands
[2] Medlon BV, Dept Clin Chem, Enschede, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Hanzepl 1, Groningen, Netherlands
[4] Univ Twente, Biomed Signals & Syst, Enschede, Netherlands
关键词
cadmium; kidney disease; lifestyle; smoking; type; 2; diabetes; BLOOD-PRESSURE CONTROL; CHRONIC KIDNEY-DISEASE; EXPOSURE; LEAD; NEPHROPATHY; TOXICITY; PROGRESSION; POPULATION;
D O I
10.1093/ndt/gfac270
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background Cadmium is an established nephrotoxin, present in cigarette smoke. We investigated the hazards of cadmium concentration and smoking status on renal function deterioration. We furthermore discerned whether the association of cadmium concentration with renal function deterioration is attributable to smoking status. Methods Prospective analyses were performed in data of 226 patients of the DIAbetes and LifEstyle Cohort Twente-1 (DIALECT). Cadmium concentrations were determined from EDTA whole-blood. Smoking status was determined via a self-administered questionnaire. Renal function deterioration was defined as need for renal replacement therapy or a persistent decline of >= 30% in estimated glomerular filtration rate from baseline for at least 3 months. Multivariable Cox regression models were performed to calculate hazard ratios (HRs) for the association between smoking status, cadmium concentration and renal function deterioration. Results Median (interquartile range) whole-blood cadmium was 2.9 (1.9-5.1) nmol/L. Active smokers had significantly higher cadmium [7.4 (3.3-11.7) nmol/L] compared with never smokers [2.6 (1.6-4.2) nmol/L] and former smokers [2.8 (1.8-4.8) nmol/L]. During median follow-up for 6 (4-8) years, renal function deterioration occurred in 60 persons (27%). Both cadmium and active smoking were associated with an increased hazard for renal function deterioration [HR 1.37, 95% confidence interval (95% CI) 1.06-1.78 and 3.77, 95% CI 1.72-8.29, respectively]. In a multivariable model with both smoking status and cadmium concentration included, active smokers have an increased risk for renal function deterioration (HR 3.00, 95% CI 1.22-7.40), while the association between cadmium and renal function deterioration lost statistical significance (HR 1.16, 95% CI 0.87-1.54). Conclusions Active smoking is associated with progressive kidney disease in type 2 diabetes. The association between cadmium concentration and renal function deterioration in large part determined by smoking status. Extensive assessment of smoking status may be useful in patients with type 2 diabetesat high risk of kidney damage.
引用
收藏
页码:876 / 883
页数:8
相关论文
共 50 条
  • [31] Challenges in achieving optimal glycemic control in type 2 diabetes patients with declining renal function: The Southeast Asia perspective
    Chow, Francis C. C.
    Chan, Siew-Pheng
    Hwu, Chii-Min
    Suwanwalaikorn, Sompongse
    Wu, Akira Y. T.
    Gan, Susan Yu
    Zacarias, Manuel B.
    JOURNAL OF DIABETES INVESTIGATION, 2012, 3 (06) : 481 - 489
  • [32] Analysis on influencing factors of abnormal renal function in elderly patients with type 2 diabetes mellitus
    Chai, Tao
    Zhang, Dawei
    Li, Zhongxin
    MINERVA ENDOCRINOLOGICA, 2020, 45 (01) : 12 - 17
  • [33] Increased urinary orosomucoid excretion is not related to impaired renal function in patients with type 2 diabetes
    Christiansen, Merete Skovdal
    Hommel, Eva
    Friberg, Lars
    Molvig, Jens
    Magid, Erik
    Feldt-Rasmussen, Bo
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2010, 24 (01) : 28 - 36
  • [34] Cadmium, type 2 diabetes, and kidney damage in a cohort of middle-aged women
    Barregard, Lars
    Bergstrom, Goran
    Fagerberg, Bjorn
    ENVIRONMENTAL RESEARCH, 2014, 135 : 311 - 316
  • [35] Changes in albuminuria and renal outcome in patients with type 2 diabetes and hypertension: a real-life observational study
    Viazzi, Francesca
    Ceriello, Antonio
    Fioretto, Paola
    Giorda, Carlo
    Guida, Pietro
    Russo, Giuseppina
    Greco, Eulalia
    De Cosmo, Salvatore
    Pontremoli, Roberto
    JOURNAL OF HYPERTENSION, 2018, 36 (08) : 1719 - 1728
  • [36] Associations of exposure to lead and cadmium with risk of all-cause and cardiovascular disease mortality among patients with type 2 diabetes
    Zhu, Kai
    Zhang, Yuge
    Lu, Qi
    Geng, Tingting
    Li, Rui
    Wan, Zhenzhen
    Zhang, Xuena
    Liu, Yujie
    Li, Lin
    Qiu, Zixin
    He, Meian
    Liu, Liegang
    Pan, An
    Liu, Gang
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2022, 29 (51) : 76805 - 76815
  • [37] Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes
    Anderson, JW
    Blake, JE
    Turner, J
    Smith, BM
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 68 (06) : 1347S - 1353S
  • [38] Progression of Diabetic Retinopathy and Declining Renal Function in Patients with Type 2 Diabetes
    Cho, AJin
    Park, Hayne Cho
    Lee, Young-Ki
    Shin, Young Joo
    Bae, So Hyun
    Kim, Hakyoung
    JOURNAL OF DIABETES RESEARCH, 2020, 2020
  • [39] The impact of weight loss on renal function in individuals with obesity and type 2 diabetes: a comprehensive review
    Gong, Xuemei
    Zeng, Xiaoxi
    Fu, Ping
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [40] Increased Risk of Renal Deterioration Associated with Low e-GFR in Type 2 Diabetes Mellitus Only in Albuminuric Subjects
    Meguro, Shu
    Shigihara, Toshikatsu
    Kabeya, Yusuke
    Tomita, Masuomi
    Atsumi, Yoshihito
    INTERNAL MEDICINE, 2009, 48 (09) : 657 - 663